Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Hepion Pharmaceuticals
Biotech
BMS banks on Wall Street vet for strategy— Chutes & Ladders
BMS tapped a Wall Street vet to shape strategy. FDA’s CBER head is adding a new title. Isomorphic Labs tapped a new CMO. And more.
Darren Incorvaia
,
Zoey Becker
Jun 20, 2025 8:30am
Merger for troubled liver disease biotech called off
Dec 11, 2024 12:43pm
In struggling Hepion, Israeli biotech spies path to go public
Jul 22, 2024 9:14am
BIO announces new CEO—Chutes & Ladders
Dec 8, 2023 9:30am
Hepion’s NASH trial hangs in balance amid cost-cutting, CEO exit
Dec 7, 2023 11:38am
Hepion shares midphase NASH data ahead of key clinical readout
May 22, 2023 7:00am
